<p>Malignancy remains the leading cause of disease-related death in children. DNA sequencing studies have shown a paucity of actionable genomic alterations and a low mutation burden across pediatric cancers at diagnosis. We perform a comprehensive genomic and epigenomic analysis of pediatric tumor and normal tissues using next-generation sequencing to identify molecular fingerprints and targets for diagnosis, prognosis, and development of novel therapeutic methods. This study also represents one of the largest of its type to date and provides a rich genomic dataset for the pediatric cancer research community.</p>

A Comprehensive Genomic Study of Pediatric Malignancy

Neuroblastoma study with RNA-Seq data on dbGaP (267 participants)

A Comprehensive Genomic Study of Pediatric Malignancy

Description

Applying For Access

Summary